Vanqua Bio
Company

Vanqua Bio

Biotechnology Research 2430 N Halsted Street 33 employees
Employees
33
Contacts
3
Emails
3
Phones
3

Vanqua Bio Overview

Headquarters
2430 N Halsted Street
Industry
Biotechnology Research
Employees
33
Founded
2019
Funding
45.0M
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Vanqua Bio

Vanqua Bio is helping usher in a new era of hope for the millions of people living with neurodegenerative diseases. Our unique drug-development approach is designed to overcome longstanding challenges in the neuroscience field by capitalizing on the power of human genetics to identify genes that cause or increase the risk of neurodegenerative disease. We leverage novel, proprietary research tools and in vitro modeling of disease, based on patient-derived neuronal cells, to develop transformative therapies that slow or stop the progression of Parkinson’s disease (PD), Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and Gaucher disease (GD).

Vanqua Bio Contact Details

People in AeroLeads
4
With contact data
3
Email contacts
3
75.0% coverage
Phone contacts
3
75.0% coverage

Vanqua Bio Org Chart

Sample employees and titles
Name Title Contact
Maurizio Facheris Chief Medical Officer at Vanqua Bio
Email Phone
Omer Siddiqui Drug Development - Biotech and Pharma
Email Phone
Y. Jennifer Hu Senior Scientist at Vanqua Bio
View
Carole Deyts Senior Scientist Iii at Vanqua Bio
Email Phone

Employees by Management Level

Senior / Lead 2 profiles
Executive 1 profile
Individual contributor 1 profile

Vanqua Bio Tech Stack

Data / AI 2 profiles

Compare Similar Companies to Vanqua Bio